Finding the right route for insulin delivery - an overview of implantable pump therapy.
Finding the right route for insulin delivery - an overview of implantable pump therapy.
复制标题
DOI:
10.1080/17425247.2017.1267138
复制
发表时间:
2017-09
影响因子:
6.6
通讯作者:
Hovorka R
中科院分区:
文献类型:
--
作者:
Bally L;Thabit H;Hovorka R
Implantable pump therapy adopting the intraperitoneal route of insulin delivery has been available for the past three decades. The key rationale for implantable pump therapy is the restoration of the portal-peripheral insulin gradient of the normal physiology. Uptake in clinical practice is limited to specialized centers and selected patient populations. Implantable pump therapy is discussed, including technical aspects, rationale for its use, and glycemic and non-glycemic effects. Target populations, summaries of clinical studies and issues related to implantable pump therapy are highlighted. Limitations of implantable pump therapy and its future outlook in clinical practice are presented. Although intraperitoneal insulin delivery appears closer to the normal physiology, technical, pharmacological, and costs barriers prevent a wider adoption. Evidence from clinical studies remains scarce and inconclusive. As a consequence, the use of implantable pump therapy will be confined to a small population unless considerable technological progress is made and well-conducted studies can demonstrate glycemic and/or non-glycemic benefits justifying wider application.
登录
查看更多内容
影响因子:
2.2
作者:
COLETTE, C;PARESHERBUTE, N;MIROUZE, J
通讯作者:
MIROUZE, J
影响因子:
15.9
作者:
Edgerton, DS;Lautz, M;Cherrington, AD
通讯作者:
Cherrington, AD
影响因子:
2.3
作者:
Haveman, Jan Willem;Logtenberg, Susan J. J.;Blomme, Adri M.
通讯作者:
Blomme, Adri M.
影响因子:
15.9
作者:
HORWITZ, DL;STARR, JI;RUBENSTEIN, AH
通讯作者:
RUBENSTEIN, AH
影响因子:
16.2
作者:
Jeandidier, N;Boullu, S;Pinget, M
通讯作者:
Pinget, M